Venture Certified
| 연구개발기업 | 1999-08-10 ~ 2001-06-30 | 1999113471-1399 | 1999-08-10 |
| 연구개발기업 | 2001-06-05 ~ 2003-06-04 | 011134211206602 | 1999-08-10 |
| 연구개발기업 | 2003-06-05 ~ 2005-06-04 | 031134221300867 | 1999-08-10 |
| 연구개발기업 | 2005-06-05 ~ 2007-06-04 | 051134221401310 | 1999-08-10 |
| 연구개발유형 | 2020-04-14 ~ 2022-04-13 | 20200104679 | 1999-08-10 |
| 연구개발유형 | 2022-04-14 ~ 2025-04-13 | 20220615020029 | 1999-08-10 |
| 혁신성장유형 | 2025-08-05 ~ 2028-08-04 | 20250805030023 | 1999-08-10 |
Revenue CAGR -27.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 57.6B | 112.1B | 108.0B |
| Operating Profit | -35.6B | 7.3B | 3.1B |
| Net Profit | -33.6B | 3.3B | 3.9B |
| Total Assets | 150.5B | 182.2B | 150.8B |
| Total Liabilities | 116.2B | 114.3B | 87.9B |
| Total Equity | 34.3B | 67.9B | 62.9B |
Operating Loss: Op. profit -36B
Revenue down 49% YoY
Debt Ratio Surge (+171pp YoY)
▼ 47.7%
▼ 784.7%
▼ 1418.0%
▲ 120.1%
▼ 1856.0%
| Name | Position | Role |
|---|---|---|
| 김철영 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전 유성구",
"ceo_name": "김철영",
"certificate": [
{
"cert_number": "1999113471-1399",
"changes": "",
"disclosure_date": "1999-08-10",
"first_cert_date": "1999-08-10",
"no": "1",
"type": "연구개발기업",
"valid_period": "1999-08-10 ~ 2001-06-30"
},
{
"cert_number": "011134211206602",
"changes": "",
"disclosure_date": "2001-06-05",
"first_cert_date": "1999-08-10",
"no": "2",
"type": "연구개발기업",
"valid_period": "2001-06-05 ~ 2003-06-04"
},
{
"cert_number": "031134221300867",
"changes": "",
"disclosure_date": "2003-06-05",
"first_cert_date": "1999-08-10",
"no": "3",
"type": "연구개발기업",
"valid_period": "2003-06-05 ~ 2005-06-04"
},
{
"cert_number": "051134221401310",
"changes": "",
"disclosure_date": "2005-06-05",
"first_cert_date": "1999-08-10",
"no": "4",
"type": "연구개발기업",
"valid_period": "2005-06-05 ~ 2007-06-04"
},
{
"cert_number": "20200104679",
"changes": "",
"disclosure_date": "2020-04-14",
"first_cert_date": "1999-08-10",
"no": "5",
"type": "연구개발유형",
"valid_period": "2020-04-14 ~ 2022-04-13"
},
{
"cert_number": "20220615020029",
"changes": "",
"disclosure_date": "2022-06-15",
"first_cert_date": "1999-08-10",
"no": "6",
"type": "연구개발유형",
"valid_period": "2022-04-14 ~ 2025-04-13"
},
{
"cert_number": "20250805030023",
"changes": "",
"disclosure_date": "2025-08-05",
"first_cert_date": "1999-08-10",
"no": "7",
"type": "혁신성장유형",
"valid_period": "2025-08-05 ~ 2028-08-04"
}
],
"company_name": "(주)사이버메드",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 1416557000,
"cost_of_sales": 3998713000,
"current_assets": 9271959000,
"current_liabilities": 7329049000,
"gross_profit": 6801717000,
"net_income": 393774000,
"net_income_bs": 393774000,
"non_current_assets": 5804754000,
"non_current_liabilities": 1458587000,
"non_operating_expenses": 452186000,
"non_operating_income": 531563000,
"operating_profit": 314397000,
"revenue": 10800430000,
"sga_expenses": 6487320000,
"total_assets": 15076713000,
"total_equity": 6289077000,
"total_liabilities": 8787636000
},
"2023": {
"capital_stock": 1424807000,
"cost_of_sales": 4312607000,
"current_assets": 12540738000,
"current_liabilities": 10324741000,
"gross_profit": 6893728000,
"net_income": 333024000,
"net_income_bs": 333024000,
"non_current_assets": 5674374000,
"non_current_liabilities": 1103834000,
"non_operating_expenses": 560187000,
"non_operating_income": 166659000,
"operating_profit": 726552000,
"revenue": 11206335000,
"sga_expenses": 6167176000,
"total_assets": 18215112000,
"total_equity": 6786537000,
"total_liabilities": 11428575000
},
"2024": {
"capital_stock": 1424807000,
"cost_of_sales": 3877882000,
"current_assets": 10660247000,
"current_liabilities": 11294034000,
"gross_profit": 1878738000,
"net_income": -3360041000,
"net_income_bs": -3360041000,
"non_current_assets": 4385140000,
"non_current_liabilities": 324858000,
"non_operating_expenses": 701750000,
"non_operating_income": 905509000,
"operating_profit": -3563800000,
"revenue": 5756620000,
"sga_expenses": 5442538000,
"total_assets": 15045387000,
"total_equity": 3426495000,
"total_liabilities": 11618892000
}
},
"industry": "응용 소프트웨어 개발 및 공급업",
"investment": [],
"main_products": "의료용 S/W, 치과용 임플란트, 3D 프린터",
"phone": "02-6959-****",
"years": [
2024,
2023,
2022
]
}